Abbott Laboratories (ABT)
112.21
+0.02
(+0.02%)
USD |
NYSE |
Feb 20, 16:00
112.00
-0.21
(-0.19%)
Pre-Market: 05:40
Abbott Laboratories Research and Development Expense (Quarterly) : 721.00M for Dec. 31, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Boston Scientific Corp. | 569.00M |
| Intuitive Surgical, Inc. | 352.90M |
| ResMed, Inc. | 90.97M |
| Insulet Corp. | 90.90M |
| Baxter International, Inc. | 116.00M |